Korea Accelerating Efforts To Develop, Launch Orphan Drugs
This article was originally published in SRA
Executive Summary
South Korea's Ministry of Food and Drug Safety has issued revised rules to ease the designation and approval of orphan drugs. The changes are expected to create an environment that would support aggressive development of orphan drugs by the domestic pharmaceutical industry and result in more treatment options for patients.